PaxVax Corporation Company Profile
PaxVax is a privately held company established in 2007 to develop and commercialize innovative and socially responsible vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio, including a cholera vaccine entering Phase 3 and a pandemic H5N1 influenza vaccine entering Phase 2. The company also has vaccines in development for HIV and anthrax under R&D contracts with NIH/DAIDS and NIH/NIAID. The companyâs proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target any viral or bacterial protein antigen. The company's vaccine candidates are designed to be easier to manufacture, store, distribute, administer and deliver across the globe than conventional injectable vaccines while enhancing the desired immune response to the vaccine antigens. The companyâs offices are headquartered in Menlo Park, Calif., and the R&D laboratories and licensed GMP production facility are based in San Diego, Calif.
News Articles
G-CON completes delivery and installation of POD system in PaxVax's GMP production facility
G-CON today announced the completed delivery and installation of the ground-breaking POD system in PaxVax's licensed GMP production facility based in San Diego, California where PaxVax manufactures in...
Paxvax PXVX0200 cholera vaccine demonstrates safety and immunogenicity in Phase 1 clinical trial
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner today announced results from a Phase 1 clinical trial of PaxVax's single-...
Berkeley, CA (PRWEB) December 19, 2012 San Francisco Bay Area branding and graphic design company Project6 Design, is proud to announce the unveiling of a new responsive design website and bran...
G-CON processing system will handle oral cholera vaccine
COLLEGE STATION, Texas, Jan. 18, 2013 /PRNewswire-iReach/ -- G-CON today announced the completed delivery and installation of the ground-breaking POD™ system in PaxVax's licensed GMP production...
PaxVax Announces Positive Results for Oral Ad4 Vaccine Technology
PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 cli...
PaxVax installs G-CON POD technology at San Diego vaccine production facility
PaxVax has installed G-CON's POD system at its GMP vaccine production facility located in San Diego, California.
PaxVax Presents Phase 1 Clinical Trial Data for Single-Dose Cholera Vaccine
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner today announced results from a Phase 1 clinical tria...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
PaxVax is a privately held company committed to developing better vaccines to better the world. Established in 2007, PaxVax has a clinical-stage product portfolio, including a cho...
PaxVax is a privately held company established in 2007 to develop and commercialize innovative and socially responsible vaccines against infectious diseases. PaxVax has a clinical...
More Information about "PaxVax Corporation" on BioPortfolio
We have published hundreds of PaxVax Corporation news stories on BioPortfolio along with dozens of PaxVax Corporation Clinical Trials and PubMed Articles about PaxVax Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PaxVax Corporation Companies in our database. You can also find out about relevant PaxVax Corporation Drugs and Medications on this site too.
